05091
3,5-Dimethylpyrazole
produced by Wacker Chemie AG, Burghausen, Germany, ≥99.0% (GC)
Sinonimo/i:
3,5-Dimethyl-1H-pyrazole
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
About This Item
Prodotti consigliati
Grado
produced by Wacker Chemie AG, Burghausen, Germany
Livello qualitativo
Saggio
≥99.0% (GC)
P. eboll.
218 °C (lit.)
Punto di fusione
105-108 °C (lit.)
Stringa SMILE
Cc1cc(C)[nH]n1
InChI
1S/C5H8N2/c1-4-3-5(2)7-6-4/h3H,1-2H3,(H,6,7)
SDXAWLJRERMRKF-UHFFFAOYSA-N
Cerchi prodotti simili? Visita Guida al confronto tra prodotti
Categorie correlate
Avvertenze
Warning
Indicazioni di pericolo
Consigli di prudenza
Classi di pericolo
Acute Tox. 4 Oral - STOT RE 2
Organi bersaglio
Liver
Codice della classe di stoccaggio
13 - Non Combustible Solids
Classe di pericolosità dell'acqua (WGK)
WGK 3
Dispositivi di protezione individuale
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Dalton transactions (Cambridge, England : 2003), (36)(36), 7428-7436 (2009-09-04)
The reactions of 3,5-dimethylpyrazole with zinc(II)acetate dihydrate and varieties of aromatic carboxylic acids led to formation of mono-nuclear zinc complexes of composition [Zn(HDMP)2(RCO2)2] (R = C6H5, p-CH3-C6H4, p-NO2-C6H4 etc. HDMP = 3,5-dimethylpyrazole) in methanol, whereas the same reactants in dimethylformamide
Rejuvenation research, 12(2), 77-84 (2009-05-08)
Aging is characterized by several metabolic changes responsible for the decline of certain functions and the appearance of age-related diseases, including hypercholesterolemia, which is the main risk factor for atherosclerosis and cardiovascular disease. Similar changes in a number of morphological
Journal of endocrinological investigation, 3(3), 237-241 (1980-07-01)
To investigate the suppressive effect of somatostatin on growth hormone secretion, a consistent, potent stimulus to growth hormone release is required. The antilipolytic compound 3,5-dimethylpyrazole (DMP) gave a rapid rise in plasma immunoreactive growth hormone following iv administration to fasting
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 56A(8), 1469-1498 (2000-07-25)
The infrared (IR) and Raman spectra of 3,5-dimethylpyrazole have been recorded in the vapor, liquid (melt and solution) and solid states. Two deuterated derivatives, C5H7N-ND and C5D7N-NH, were also studied in solid state and in solutions. Instrumental resolution was relatively
Biochimica et biophysica acta, 839(1), 96-104 (1985-03-29)
The mechanisms involved in the inhibitory effects of antilipolytic agents on rat liver peroxisomal fatty acid oxidative activity have been explored. Treatment of fasting rats with antilipolytic drugs (either 3,5-dimethylpyrazole (12 mg/kg body weight) or Acipimox (25 mg/kg body weight]
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.